Moreover, polydatin was found to exhibit desirable pharmacological activities in proliferation and metastasis inhibition in hepatocellular carcinoma cells by targeting PI3K/Akt pathway [35]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.